Biotech VC Partners is pleased to announce the signing of a Term Sheet for the acquisition of a 50% equity stake in Bioanalytica, a company specializing in the production of high-quality laboratory reagents. This strategic investment reflects our commitment to advancing innovation in the biotech sector and expanding our footprint in the life sciences industry. The transaction is expected to close on August 30, 2025, pending final documentation and regulatory approvals.
